Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Use of drugs known to cause fetal harm among women delivering infants in Haiti.

Jules A, Kaltenbach LA, Arbogast PG, Caples TL, Po'e EK, Cooper WO.

Acad Pediatr. 2010 Nov-Dec;10(6):395-9. doi: 10.1016/j.acap.2010.09.003.

PMID:
21075320
2.

Use of prescription medications with a potential for fetal harm among pregnant women.

Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA, Fortman KK, McPhillips H, Roblin D, Smith DH, Yood MU, Platt R, H Gurwitz J.

Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):546-54.

PMID:
16586470
3.

Severe morbidities associated with induced abortions among misoprostol users and non-users in a tertiary public hospital in Ghana.

Damalie FJ, Dassah ET, Morhe ES, Nakua EK, Tagbor HK, Opare-Addo HS.

BMC Womens Health. 2014 Jul 29;14:90. doi: 10.1186/1472-6874-14-90.

4.

Prescriptions filled during pregnancy for drugs with the potential of fetal harm.

Kulaga S, Zargarzadeh AH, Bérard A.

BJOG. 2009 Dec;116(13):1788-95. doi: 10.1111/j.1471-0528.2009.02377.x. Erratum in: BJOG. 2010 Feb;117(3):373. Zagarzadeh, A [corrected to Zargarzadeh, A H].

5.

Use of misoprostol during pregnancy and Möbius' syndrome in infants.

Pastuszak AL, Schüler L, Speck-Martins CE, Coelho KE, Cordello SM, Vargas F, Brunoni D, Schwarz IV, Larrandaburu M, Safattle H, Meloni VF, Koren G.

N Engl J Med. 1998 Jun 25;338(26):1881-5.

6.

Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy.

Gonzalez CH, Marques-Dias MJ, Kim CA, Sugayama SM, Da Paz JA, Huson SM, Holmes LB.

Lancet. 1998 May 30;351(9116):1624-7.

PMID:
9620717
7.

Prevalence and clinical correlates of unsuccessful use of drugs to induce menstruation.

Mengue SS, Schenkel EP, Duncan BB, Schmidt MI.

Contraception. 1998 Feb;57(2):93-7.

PMID:
9589835
8.
9.

Use of misoprostol for self-induced medical abortions among Saudi women: a call for attention.

Alsibiani SA.

Gynecol Obstet Invest. 2014;78(2):88-93. doi: 10.1159/000363238.

PMID:
24993350
10.

Determinants of abortion among women admitted to hospitals in Fortaleza, North Eastern Brazil.

Misago C, Fonseca W, Correia L, Fernandes LM, Campbell O.

Int J Epidemiol. 1998 Oct;27(5):833-9.

11.
12.

Cholera in pregnancy: outcomes from a specialized cholera treatment unit for pregnant women in Léogâne, Haiti.

Ciglenecki I, Bichet M, Tena J, Mondesir E, Bastard M, Tran NT, Antierens A, Staderini N.

PLoS Negl Trop Dis. 2013 Aug 15;7(8):e2368. doi: 10.1371/journal.pntd.0002368.

13.

Buccal misoprostol for treatment of fetal death at 14-28 weeks of pregnancy: a double-blind randomized controlled trial.

Bracken H, Ngoc NT, Banks E, Blumenthal PD, Derman RJ, Patel A, Gold M, Winikoff B; Buccal misoprostol for IUFD Research Group..

Contraception. 2014 Mar;89(3):187-92. doi: 10.1016/j.contraception.2013.11.014.

PMID:
24405797
14.

Neonatal morbidity and outcome of live born premature babies after attempted illegal abortion with misoprostol.

Escumalha M, Gouveia C, Cunha M, Vale F, Machado MC.

Pediatr Nurs. 2005 May-Jun;31(3):228-31.

PMID:
16060589
15.

Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women.

Cleary BJ, Butt H, Strawbridge JD, Gallagher PJ, Fahey T, Murphy DJ.

Pharmacoepidemiol Drug Saf. 2010 Apr;19(4):408-17. doi: 10.1002/pds.1906.

PMID:
20099251
16.

A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion.

Jain JK, Mishell DR Jr.

Am J Obstet Gynecol. 1996 Jul;175(1):173-7.

PMID:
8694046
17.
18.
20.

Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial.

Winikoff B, Dzuba IG, Creinin MD, Crowden WA, Goldberg AB, Gonzales J, Howe M, Moskowitz J, Prine L, Shannon CS.

Obstet Gynecol. 2008 Dec;112(6):1303-10. doi: 10.1097/AOG.0b013e31818d8eb4.

PMID:
19037040
Items per page

Supplemental Content

Support Center